S. Abdolmaleki Et Al. , "An in silico investigation on the binding site preference of PD-1 and PD-L1 for designing antibodies for targeted cancer therapy," PLoS ONE , vol.19, no.7 July, 2024
Abdolmaleki, S. Et Al. 2024. An in silico investigation on the binding site preference of PD-1 and PD-L1 for designing antibodies for targeted cancer therapy. PLoS ONE , vol.19, no.7 July .
Abdolmaleki, S., GANJALI KHANI HAKEMI, M., & Ganjalikhany, M. R., (2024). An in silico investigation on the binding site preference of PD-1 and PD-L1 for designing antibodies for targeted cancer therapy. PLoS ONE , vol.19, no.7 July.
Abdolmaleki, Sarah, MAZDAK GANJALI KHANI HAKEMI, And Mohamad Reza Ganjalikhany. "An in silico investigation on the binding site preference of PD-1 and PD-L1 for designing antibodies for targeted cancer therapy," PLoS ONE , vol.19, no.7 July, 2024
Abdolmaleki, Sarah Et Al. "An in silico investigation on the binding site preference of PD-1 and PD-L1 for designing antibodies for targeted cancer therapy." PLoS ONE , vol.19, no.7 July, 2024
Abdolmaleki, S. GANJALI KHANI HAKEMI, M. And Ganjalikhany, M. R. (2024) . "An in silico investigation on the binding site preference of PD-1 and PD-L1 for designing antibodies for targeted cancer therapy." PLoS ONE , vol.19, no.7 July.
@article{article, author={Sarah Abdolmaleki Et Al. }, title={An in silico investigation on the binding site preference of PD-1 and PD-L1 for designing antibodies for targeted cancer therapy}, journal={PLoS ONE}, year=2024}